Profiel
Jack Slovick is currently the VP-Quality Assurance & Regulatory Affairs at Wound Care Technologies, Inc. and the President at Methodize, Inc. He previously worked as the Director-Regulatory Affairs & Quality Assurance at Celleration, Inc., the Director-Quality & Regulatory Affairs at NeuroVasx, Inc., and the Manager-Regulatory & Quality Systems at Possis Medical, Inc.
Actieve functies van Jack Slovick
Bedrijven | Functie | Begin |
---|---|---|
Wound Care Technologies, Inc.
Wound Care Technologies, Inc. Pharmaceuticals: MajorHealth Technology Wound Care Technologies, Inc. develops wound care products. It offers DermaClose, used as alternative to skin grafts and other treatment modalities such as negative pressure wound therapy. The company was founded by Paul J. Anderson, Robert C. Wilke, and George M. Hoedeman in 2004 and is headquartered in Chanhassen, MN. | Algemeen Adviseur | 19-04-2010 |
Methodize, Inc. | President | - |
Eerdere bekende functies van Jack Slovick
Bedrijven | Functie | Einde |
---|---|---|
Celleration, Inc.
Celleration, Inc. Medical SpecialtiesHealth Technology Celleration, Inc. manufactured medical devices. It developed and marketed a proprietary technology to accelerate healing in wounds by delivering therapeutic, low frequency ultrasound without direct contact of the delivery device to the wound surface. The firm’s core product was the MIST Therapy System, impacted all critical aspects of the wound healing process providing clinical and economic benefits to institutions treating nonresponding wounds. The company was founded by Gene Berghoff, Dennis L. Davey and Eliaz P. Babaev in 1999 and was headquartered in Eden Prairie, MN. | Algemeen Adviseur | - |
Possis Medical, Inc.
Possis Medical, Inc. Medical SpecialtiesHealth Technology Possis Medical, Inc. develops, manufactures and markets innovative medical products such as disposable catheters. It engages in the development, manufacturing and marketing of medical devices for the cardiovascular and vascular treatment markets. It's primary product is AngioJet Rheolytic Thrombectomy System, a nonsurgical, minimally invasive catheter system used for blood clot removal from native coronary arteries, leg arteries, coronary bypass grafts and AV dialysis access grafts. The company offers its system to interventional cardiologists, interventional radiologists, vascular surgeons, nephrologists and osteopaths. It also offers XMI, XMI-RX, XMI RX +, Spiroflex, XVG, Xpeedior, DVX and AVX line of catheters. The company was founded in 1952 and is headquartered in Minneapolis, MN. | Algemeen Adviseur | - |
NeuroVasx, Inc.
NeuroVasx, Inc. Medical SpecialtiesHealth Technology NeuroVasx, Inc. engages in the development of technologies for the treatment of strokes. The company was founded by Lee A Jeffrey in 1997 and is headquartered in Excelsior, MN. | Algemeen Adviseur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
Wound Care Technologies, Inc.
Wound Care Technologies, Inc. Pharmaceuticals: MajorHealth Technology Wound Care Technologies, Inc. develops wound care products. It offers DermaClose, used as alternative to skin grafts and other treatment modalities such as negative pressure wound therapy. The company was founded by Paul J. Anderson, Robert C. Wilke, and George M. Hoedeman in 2004 and is headquartered in Chanhassen, MN. | Health Technology |
NeuroVasx, Inc.
NeuroVasx, Inc. Medical SpecialtiesHealth Technology NeuroVasx, Inc. engages in the development of technologies for the treatment of strokes. The company was founded by Lee A Jeffrey in 1997 and is headquartered in Excelsior, MN. | Health Technology |
Celleration, Inc.
Celleration, Inc. Medical SpecialtiesHealth Technology Celleration, Inc. manufactured medical devices. It developed and marketed a proprietary technology to accelerate healing in wounds by delivering therapeutic, low frequency ultrasound without direct contact of the delivery device to the wound surface. The firm’s core product was the MIST Therapy System, impacted all critical aspects of the wound healing process providing clinical and economic benefits to institutions treating nonresponding wounds. The company was founded by Gene Berghoff, Dennis L. Davey and Eliaz P. Babaev in 1999 and was headquartered in Eden Prairie, MN. | Health Technology |
Possis Medical, Inc.
Possis Medical, Inc. Medical SpecialtiesHealth Technology Possis Medical, Inc. develops, manufactures and markets innovative medical products such as disposable catheters. It engages in the development, manufacturing and marketing of medical devices for the cardiovascular and vascular treatment markets. It's primary product is AngioJet Rheolytic Thrombectomy System, a nonsurgical, minimally invasive catheter system used for blood clot removal from native coronary arteries, leg arteries, coronary bypass grafts and AV dialysis access grafts. The company offers its system to interventional cardiologists, interventional radiologists, vascular surgeons, nephrologists and osteopaths. It also offers XMI, XMI-RX, XMI RX +, Spiroflex, XVG, Xpeedior, DVX and AVX line of catheters. The company was founded in 1952 and is headquartered in Minneapolis, MN. | Health Technology |
Methodize, Inc. |